Alvotech
(NASDAQ : ALVO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.09%167.720.7%$1125.55m
PFEPfizer Inc. -0.95%49.390.9%$919.53m
ABBVAbbVie, Inc. -0.72%141.521.9%$813.82m
LLYEli Lilly & Co. 2.22%317.211.1%$802.60m
MRKMerck & Co., Inc. 0.48%91.020.7%$796.67m
BMYBristol-Myers Squibb Co. 0.49%74.501.0%$649.17m
SIGASIGA Technologies, Inc. 2.06%24.820.0%$473.79m
AZNAstraZeneca Plc -0.37%66.501.0%$368.34m
GBTGlobal Blood Therapeutics, Inc. 0.04%67.035.6%$332.88m
GSKGSK Plc -1.67%34.670.3%$279.48m
ALNYAlnylam Pharmaceuticals, Inc. -2.02%223.548.2%$270.93m
VERUVeru, Inc. 7.20%23.850.0%$240.32m
HZNPHorizon Therapeutics Plc -3.07%62.115.4%$213.77m
KRTXKaruna Therapeutics, Inc. -0.51%262.340.0%$203.98m
CCXIChemoCentryx, Inc. -0.03%50.852.9%$202.28m

Company Profile

Alvotech operates as a global biopharmaceutical company, which engages in developing and manufacturing biosimilar medicines through its subsidiaries. The firm's pipeline contains biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. The company was founded on August 23, 2021 and is headquartered in Luxembourg.